Research Article
Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis
Table 2
Baseline characteristics of the enrolled patients.
| | | Mean ± SD | Range |
| | Age (years) | 47.4 ± 9.3 | 18–75 | | Weight (kg) | 78.2 ± 14.7 | 48–110 | | Total bilirubin (mg/dL) | 3.9 ± 3.2 | 0.6–17.5 | | Albumin (g/dL) | 2.6 ± 0.5 | 1.7–3.5 | | Isotopic GFR (mL/min) | 84.5 ± 16.6 | 53–133 | | BUN (mg/dL) | 19.3 ± 10.8 | 4.7–72.3 | | Creatinine (mg/dL) | 0.8 ± 0.3 | 0.3–1.4 | | Creatinine clearance (mL/min) | 82.4 ± 31.3 | 24–199 | | Cystatin C (mg/L) | 1.9 ± 1 | 0.3–4.5 | | Child-Pugh score | 10.7 ± 1.7 | 7–14 | | MELD score | 16.2 ± 4.9 | 8–31 | | MDRD 4 (mL/min) | 119.2 ± 63.5 | 45.7–367 | | MDRD 6 (mL/min) | 97.4 ± 50.4 | 28.4–291.7 | | Cockcroft-Gault formula (mL/min) | 132.9 ± 65 | 47.9–421.1 | | CKD-EPI-Cr (mL/min) | 101.0 ± 26.7 | 47.1–175.6 | | CKD-EPI-CysC (mL/min) | 52 ± 40 | 11.4–185.9 | | CKD-EPI-Cr-CysC (mL/min) | 61.5 ± 26.3 | 29.7–154.8 |
|
|
BUN, blood urea nitrogen; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; GFR, glomerular filtration rate; MDRD, modification of diet in renal disease equation with 4 and 6 variables; MELD, model for end-stage liver disease; SD, standard deviation.
|
